NEW YORK (AP) -- Mylan N.V. rejected Teva Pharmaceuticals' $40.1 billion buyout offer, saying the cash-and-stock proposal undervalues the company....
Associated Press: Business
Mon, 04/27/2015 - 6:58am
NEW YORK (AP) -- Mylan N.V. rejected Teva Pharmaceuticals' $40.1 billion buyout offer, saying the cash-and-stock proposal undervalues the company....